199 related articles for article (PubMed ID: 20044868)
1. Metabolic syndrome and elevated C-reactive protein in breast cancer survivors on adjuvant hormone therapy.
Thomson CA; Thompson PA; Wright-Bea J; Nardi E; Frey GR; Stopeck A
J Womens Health (Larchmt); 2009 Dec; 18(12):2041-7. PubMed ID: 20044868
[TBL] [Abstract][Full Text] [Related]
2. An observational study to examine changes in metabolic syndrome components in patients with breast cancer receiving neoadjuvant or adjuvant chemotherapy.
Dieli-Conwright CM; Wong L; Waliany S; Bernstein L; Salehian B; Mortimer JE
Cancer; 2016 Sep; 122(17):2646-53. PubMed ID: 27219902
[TBL] [Abstract][Full Text] [Related]
3. Risk of metabolic syndrome in postmenopausal breast cancer survivors.
Buttros Dde A; Nahas EA; Vespoli Hde L; Uemura G; de Almeida Bda R; Nahas-Neto J
Menopause; 2013 Apr; 20(4):448-54. PubMed ID: 23149866
[TBL] [Abstract][Full Text] [Related]
4. [Metabolic syndrome in postmenopausal breast cancer survivors].
Nahas EA; de Almeida Bda R; Buttros Dde A; Véspoli Hde L; Uemura G; Nahas-Neto J
Rev Bras Ginecol Obstet; 2012 Dec; 34(12):555-62. PubMed ID: 23329285
[TBL] [Abstract][Full Text] [Related]
5. Metabolic Obesity Phenotypes and Risk of Breast Cancer in Postmenopausal Women.
Kabat GC; Kim MY; Lee JS; Ho GY; Going SB; Beebe-Dimmer J; Manson JE; Chlebowski RT; Rohan TE
Cancer Epidemiol Biomarkers Prev; 2017 Dec; 26(12):1730-1735. PubMed ID: 28939589
[No Abstract] [Full Text] [Related]
6. Exercise after diagnosis and metabolic syndrome among breast cancer survivors: a report from the Shanghai Breast Cancer Survival Study.
Bao PP; Zheng Y; Nechuta S; Gu K; Cai H; Peng P; Shu XO; Lu W
Cancer Causes Control; 2013 Sep; 24(9):1747-56. PubMed ID: 23860950
[TBL] [Abstract][Full Text] [Related]
7. Metabolic syndrome and its associated risk factors in Brazilian postmenopausal women.
Petri Nahas EA; Padoani NP; Nahas-Neto J; Orsatti FL; Tardivo AP; Dias R
Climacteric; 2009 Oct; 12(5):431-8. PubMed ID: 19415539
[TBL] [Abstract][Full Text] [Related]
8. The most appropriate cut-off point of anthropometric indices in predicting the incidence of metabolic syndrome and its components.
Farhangiyan Z; Latifi SM; Rashidi H; Shahbazian H
Diabetes Metab Syndr; 2019; 13(4):2739-2745. PubMed ID: 31405702
[TBL] [Abstract][Full Text] [Related]
9. Metabolic and anthropometric changes in early breast cancer patients receiving adjuvant therapy.
Arpino G; De Angelis C; Buono G; Colao A; Giuliano M; Malgieri S; Cicala S; De Laurentiis M; Accurso A; Crispo A; Limite G; Lauria R; Veneziani BM; Forestieri V; Bruzzese D; De Placido S
Breast Cancer Res Treat; 2015 Nov; 154(1):127-32. PubMed ID: 26424165
[TBL] [Abstract][Full Text] [Related]
10. Could Anthropometric and Lipid Parameters Reflect Susceptibility to Breast Cancer? Comparison of Newly Diagnosed Breast Cancer and Apparently Healthy Women.
Akalanka HMK; Ekanayake S; Samarasinghe K
Asian Pac J Cancer Prev; 2018 Sep; 19(9):2475-2480. PubMed ID: 30255702
[TBL] [Abstract][Full Text] [Related]
11. The prevalence of metabolic syndrome in Chinese postmenopausal women and the optimum body composition indices to predict it.
Ruan X; Jin J; Hua L; Liu Y; Wang J; Liu S
Menopause; 2010; 17(3):566-70. PubMed ID: 20054286
[TBL] [Abstract][Full Text] [Related]
12. The presentation of metabolic dysfunction and the relationship with energy output in breast cancer survivors: a cross-sectional study.
Guinan EM; Connolly EM; Kennedy MJ; Hussey J
Nutr J; 2013 Jul; 12():99. PubMed ID: 23855321
[TBL] [Abstract][Full Text] [Related]
13. Associations of metabolic syndrome and C-reactive protein with mortality from total cancer, obesity-linked cancers and breast cancer among women in NHANES III.
Gathirua-Mwangi WG; Song Y; Monahan PO; Champion VL; Zollinger TW
Int J Cancer; 2018 Aug; 143(3):535-542. PubMed ID: 29488212
[TBL] [Abstract][Full Text] [Related]
14. Examining the prevalence of metabolic syndrome among overweight/obese African-American breast cancer survivors vs. matched non-cancer controls.
Sheean P; Liang H; Schiffer L; Arroyo C; Stolley M
J Cancer Surviv; 2017 Feb; 11(1):102-110. PubMed ID: 27562474
[TBL] [Abstract][Full Text] [Related]
15. Metabolic syndrome affects breast cancer risk in postmenopausal women: National Cancer Institute of Naples experience.
Capasso I; Esposito E; Pentimalli F; Crispo A; Montella M; Grimaldi M; De Marco M; Cavalcanti E; D'Aiuto M; Fucito A; Frasci G; Maurea N; Esposito G; Pedicini T; Vecchione A; D'Aiuto G; Giordano A
Cancer Biol Ther; 2010 Dec; 10(12):1240-3. PubMed ID: 20935521
[TBL] [Abstract][Full Text] [Related]
16. Associations Between Serum Uric Acid Concentrations and Cardiometabolic Risk and Renal Injury in Obese and Overweight Children.
Özalp Kızılay D; Şen S; Ersoy B
J Clin Res Pediatr Endocrinol; 2019 Sep; 11(3):262-269. PubMed ID: 30759960
[TBL] [Abstract][Full Text] [Related]
17. The effect of aerobic exercise on metabolic and inflammatory markers in breast cancer survivors--a pilot study.
Guinan E; Hussey J; Broderick JM; Lithander FE; O'Donnell D; Kennedy MJ; Connolly EM
Support Care Cancer; 2013 Jul; 21(7):1983-92. PubMed ID: 23430010
[TBL] [Abstract][Full Text] [Related]
18. Serum adiponectin and resistin: Correlation with metabolic syndrome and its associated criteria among temiar subtribe in Malaysia.
Zahary MN; Harun NS; Yahaya R; Nik Him NAS; Rohin MAK; Ridzwan NH; Jumli MN; Wan Jusoh AF
Diabetes Metab Syndr; 2019; 13(3):2015-2019. PubMed ID: 31235129
[TBL] [Abstract][Full Text] [Related]
19. Feasibility of a lifestyle intervention on body weight and serum biomarkers in breast cancer survivors with overweight and obesity.
Campbell KL; Van Patten CL; Neil SE; Kirkham AA; Gotay CC; Gelmon KA; McKenzie DC
J Acad Nutr Diet; 2012 Apr; 112(4):559-67. PubMed ID: 22709706
[TBL] [Abstract][Full Text] [Related]
20. Key metabolic parameters change significantly in early breast cancer survivors: an explorative PILOT study.
Fredslund SO; Gravholt CH; Laursen BE; Jensen AB
J Transl Med; 2019 Apr; 17(1):105. PubMed ID: 30935397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
